DUBLIN–(BUSINESS WIRE)–The “Opportunities in Personalized Nutrition Solutions, Microbiome Testing for Optimal Health, Gene Circuits and Advanced Therapeutics” report has been added to ResearchAndMarkets.com’s providing.
This version of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) focuses on host microbiome evaluation pushed personalised vitamin options and precision probiotics growth. Newer drug supply carriers resembling RBC derived vesicles, non viral gene supply carriers and some improvements round gene circuits for superior therapeutics have additionally been coated.
The Life Science, Health & Wellness TOE will characteristic disruptive know-how advances within the international life sciences business. The applied sciences and improvements profiled will embody developments throughout genetic engineering, drug discovery and growth, biomarkers, tissue engineering, artificial biology, microbiome, illness administration, in addition to well being and wellness amongst a number of different platforms.
The Health & Wellness cluster tracks developments in a myriad of areas together with genetic engineering, regenerative medication, drug discovery and growth, nanomedicine, vitamin, beauty procedures, ache and illness administration and therapies, drug supply, personalised medication, and sensible healthcare.
Key Topics Covered:
Innovations in Life Science, Health & Wellness
- Red Blood Cell Extracellular Vesicles for Non-viral Gene Therapy
- Value Proposition of Carmine Therapeutics
- Carmine Therapeutics – Investor Dashboard
- Genetic Lysis Circuit Based Therapeutics That Targets Hypoxic Cancerous Tumor Areas
- Gencirq – Value Proposition
- Gencirq – Investor Dashboard
- Mushroom-derived Personal Care Products To Improve Hair Strand Properties
- Active Concepts – Value Proposition
- Active Concepts – Investor Dashboard
- Naturally Derived Optimized Peptides For Wide-ranging Health Benefits
- Nuritas – Value Proposition
- Nuritas – Investor Dashboard
- Cloud Based Bioreactor Design for Process Monitoring and Optimization
- Culture Bioscience’s Value Proposition
- Culture Bioscience – Investor Dashboard
- Developing Cell-free Manufacturing Platform for Gene Therapy
- Intergalactic Therapeutics’s Value Proposition
- Intergalactic Therapeutics – Investor Dashboard
- Customized Mixed Consortia Probiotics Tailored to the Patient’s Gut
- Probiotics with the Potential to Address Autism Spectrum Disorder
- Sun Genomics – Investor Dashboard
- AI-based Precision Nutrition Guidance Solution for Optimal Nutrition
- Personalized Solution Enabling Optimal Health and Performance
- Me Biosciences Inc. – Investor Dashboard
- Oral Insulin Tablets as a Promising Alternative to Insulin Injections
- The University of British Columbia’s Value Proposition
- Next Generation Monoclonal Antibody for Treating Refractive Rheumatoid Arthritis
- The Medical University of Vienna’s Value Proposition
- Multi-layered Gene Circuits Open Up New Avenues in Next-generation Medicine Discovery
- University of Washington’s Value Proposition
- Key Contacts
Appendix
- Criteria for Rating of Innovations – Explanation
- Legal Disclaimer
Companies Mentioned
- Active Concepts
- Carmine Therapeutics
- Culture Bioscience
- Gencirq
- Intergalactic Therapeutics
- Me Biosciences Inc
- Nuritas
- Sun Genomics
For extra details about this report go to https://www.researchandmarkets.com/r/fjvtt
https://news.google.com/__i/rss/rd/articles/CBMijgJodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIyMTIwOTAwNTIyMS9lbi9PcHBvcnR1bml0aWVzLWluLVBlcnNvbmFsaXplZC1OdXRyaXRpb24tU29sdXRpb25zLU1pY3JvYmlvbWUtVGVzdGluZy1mb3ItT3B0aW1hbC1IZWFsdGgtR2VuZS1DaXJjdWl0cy1hbmQtQWR2YW5jZWQtVGhlcmFwZXV0aWNzLUZlYXR1cmluZy1NaWNyb2Jpb21lLUFuYWx5c2lzLUJhc2VkLU51dHJpdGlvbi1Tb2x1dGlvbnMtTW9yZS0tLVJlc2VhcmNoQW5kTWFya2V0cy5jb23SAQA?oc=5
